Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.

Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.

It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Gloyn, A, Faber, J, Malmodin, D, Thanabalasingham, G, Lam, F, Ueland, P, McCarthy, M, Owen, K, Baunsgaard, D
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science 2012

Míreanna comhchosúla

Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
de réir: Anna L Gloyn, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Diagnosis and management of maturity onset diabetes of the young (MODY).
de réir: Thanabalasingham, G, et al.
Foilsithe / Cruthaithe: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY).
de réir: Thanabalasingham, G, et al.
Foilsithe / Cruthaithe: (2011)

Diagnosis and management of maturity onset diabetes of the young (MODY)
de réir: Thanabalasingham, G, et al.
Foilsithe / Cruthaithe: (2011)

Mature onset diabetes of the young (MODY).
de réir: E Lacerda Nobre, et al.
Foilsithe / Cruthaithe: (2002-12-01)

Extending criteria for genetic testing increases diagnosis of maturity-onset diabetes of the young
de réir: Thanabalasingham, G, et al.
Foilsithe / Cruthaithe: (2010)

Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
de réir: Thanabalasingham, G, et al.
Foilsithe / Cruthaithe: (2012)

Maturity onset diabetes of the young and fibrin-related thrombosis risk
de réir: Sagar, RC, et al.
Foilsithe / Cruthaithe: (2020)

Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations.
de réir: Owen, K, et al.
Foilsithe / Cruthaithe: (2010)

Clinical features and treatment of maturity onset diabetes of the young (MODY)
de réir: Gardner DS,Tai ES
Foilsithe / Cruthaithe: (2012-05-01)

Update on clinical screening of maturity-onset diabetes of the young (MODY)
de réir: Renata Peixoto-Barbosa, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Precision diabetes: Lessons learned from maturity‐onset diabetes of the young (MODY)
de réir: Mustafa Tosur, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment
de réir: Urakami T
Foilsithe / Cruthaithe: (2019-07-01)

Identification and assessment of glycan profiles as a biomarker for maturity onset diabetes of the young (MODY) due to hepatocyte nuclear factor 1 alpha (HNF1A) mutations
de réir: Gloyn, A, et al.
Foilsithe / Cruthaithe: (2011)

Differences in thrombotic and inflammatory markers comparing subjects with maturity onset diabetes of the young and type 2 diabetes
de réir: Bottomley, M, et al.
Foilsithe / Cruthaithe: (2010)

The coexistence of autoimmune diabetes and maturity-onset diabetes of the young (MODY): a case series
de réir: Eimear Mary O’Donovan, et al.
Foilsithe / Cruthaithe: (2022-07-01)

MODY diabetes: adult-onset type diabetes in the young
de réir: Adela-Emilia Gómez Ayala
Foilsithe / Cruthaithe: (2010-02-01)

Maturity onset diabetes of the young due to HNF1A variants in Croatia
de réir: Pavić, T, et al.
Foilsithe / Cruthaithe: (2018)

High-Throughput HPLC-based N-Glycan Analysis of Human Plasma Proteins Identifies Potential Biomarkers for Maturity Onset Diabetes of the Young (MODY)
de réir: Adamczyk, B, et al.
Foilsithe / Cruthaithe: (2011)

Examining the clinical and genetic spectrum of maturity-onset diabetes of the young (MODY) in Iran
de réir: Sara Asgarian, et al.
Foilsithe / Cruthaithe: (2024-08-01)

ASPECTOS CLÍNICOS E MOLECULARES DO MATURITY-ONSET DIABETES OF THE YOUNG (MODY)
de réir: Nicole Campagnolo, et al.
Foilsithe / Cruthaithe: (2020-03-01)

The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY)
de réir: Ken Munene Nkonge, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.
de réir: Winckler, W, et al.
Foilsithe / Cruthaithe: (2007)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
de réir: Thomson, K, et al.
Foilsithe / Cruthaithe: (2003)

Diabetes mellitus – analysis of gene variants associated with subtypes of Maturity-Onset Diabetes of the Young (MODY)
de réir: Lise Bjørkhaug Gundersen, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic
de réir: Hessa Al-Kandari, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends
de réir: Tajudeen O. Yahaya, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12)
de réir: Juyi Li, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
de réir: Gloyn, A
Foilsithe / Cruthaithe: (2003)

Molecular genetics of maturity-onset diabetes of the young
de réir: M I Voevoda, et al.
Foilsithe / Cruthaithe: (2016-04-01)

Maturity onset diabetes of the young: clinical characteristics, diagnosis and management.
de réir: Kavvoura, F, et al.
Foilsithe / Cruthaithe: (2012)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
de réir: Li, Xiuzhen, et al.
Foilsithe / Cruthaithe: (2018)

Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY)
de réir: Xiuzhen Li, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Maturity onset diabetes of the young is characterised by less thrombotic fibrin network structure compared with phenotypically similar type 2 diabetes subjects
de réir: Ajjan, R, et al.
Foilsithe / Cruthaithe: (2011)

MATURITY-ONSET DIABETES IN YOUNG BLACK-AMERICANS
de réir: Orahilly, S, et al.
Foilsithe / Cruthaithe: (1987)

Recognition of maturity‐onset diabetes of the young in China
de réir: Hua Liang, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
de réir: Bouldjennet F, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Maturity-Onset Diabetes of the Young (MODY): Genetic Causes, Clinical Characteristics, Considerations for Testing, and Treatment Options
de réir: Zoltan Antal
Foilsithe / Cruthaithe: (2021-12-01)

Further evidence that mutations in <it>INS </it>can be a rare cause of Maturity-Onset Diabetes of the Young (MODY)
de réir: Pisinger Charlotta, et al.
Foilsithe / Cruthaithe: (2010-03-01)

Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India
de réir: Viswanathan Mohan, et al.
Foilsithe / Cruthaithe: (2018-02-01)